SA
MRK icon

SpiderRock Advisors’s Merck MRK Stock Holding History

SpiderRock Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$15M Buy
132,262
+14,774
+13% +$1.76M 0.24% 65
2024
Q2 		$14.5M Buy
117,488
+21,312
+22% +$2.75M 0.29% 56
2024
Q1 		$11.7M Buy
+96,176
New +$11.9M 0.29% 63
2017
Q1 		– Hold
0
– – – 108

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SpiderRock Advisors's MRK Position: Q3 2024 in Review

SpiderRock Advisors increased its Merck (MRK) stake by 13% in Q3 2024, buying an estimated $1.76M and bringing the position to 132,262 shares worth $15M. The position accounts for 0.24% of the portfolio, ranked #65.

SpiderRock Advisors first reported a position in MRK in Q1 2024 and has held it in 3 quarters since. 3,490 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • SpiderRock Advisors held 132,262 shares of Merck worth $15M as of Q3 2024.
  • SpiderRock Advisors bought 14,774 Merck shares in Q3 2024, an estimated $1.76M.
  • Merck made up 0.24% of SpiderRock Advisors's portfolio in Q3 2024, its #65 holding.
  • SpiderRock Advisors first reported a position in Merck in Q1 2024 and has held it in 3 quarters since.
  • 3,490 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on SpiderRock Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.